Last checked at 6 Apr 2023 17:53
6 April 2023
Inspiration Healthcare Group plc
("Inspiration Healthcare" or the "Company")
Grant of Options under Sharesave Scheme
Inspiration Healthcare Group plc (AIM: IHC), the global medical device company, announces that it has granted a total of 232,105 options over ordinary shares of 10 pence each in the capital of the Company ("Options") on 6 April 2023, under the Company's Sharesave Scheme (the "Scheme"), the terms of which were announced on 30 March 2020, including a total of 35,640 Options to four Persons Discharging Managerial Responsibilities ("PDMRs") as detailed below.
The Scheme is available to all employees subject to qualifying conditions. The Scheme was introduced to encourage wider employee share ownership of the Company. The Options are exercisable after three years at an exercise price of 40.4 pence, being a 20 per cent. discount to the closing price on 14 March 2023.
For further information:
Inspiration Healthcare Group plc Neil Campbell, Chief Executive Officer | Tel: +44 (0)330 175 0000
| |
Cenkos Securities plc (Nominated Adviser & Broker) | Tel: +44 (0)207 397 8900 | |
Stephen Keys, Katy Birkin, Dan Hodkinson | ||
Walbrook PR Ltd (Media and Investor Relations) | Tel: +44 (0)20 7933 8780 | |
Anna Dunphy/Stephanie Cuthbert | ||
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | 1. Neil Campbell 2. Brook Nolson 3. Peter Reynolds 4. Martin Pearcy
| ||||
2 | Reason for the notification | |||||
a) | Position/status | 1. PDMR 2. PDMR 3. PDMR 4. PDMR | ||||
b) | Initial notification /Amendment | Initial | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Inspiration Healthcare Group plc
| ||||
b) | LEI | 213800GKFT3ENAPMDL15
| ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a)
| Description of the financial instrument, type of instrument Identification code | Options over Ordinary Shares of 10p each in the capital of the Company ISIN: GB00BXDZL105 | ||||
b) | Nature of the transaction | Grant of Options under the Company's Sharesave Scheme | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information - Aggregated volume - Price |
N/A - single transaction
| ||||
e) | Date of the transaction | 6 April 2023 | ||||
f) | Place of the transaction | Outside of a trading venue | ||||
About Inspiration Healthcare
Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in neonatal intensive care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.
The Company has key own brand products that can be used within the first days of life to help premature and sick babies; helping resuscitation and stabilisation in the first moments of life through to preventing brain damage and both invasive and non-invasive respiratory support in terms of capital equipment and disposable medical devices. Additionally, the Company has its own range of products for maintaining normothermia pre, during and post-surgery.
Since September 2019, the Company has acquired Vio Holdings a designer, manufacturer and supplier of single use respiratory products and sterile medical consumables and S.L.E., a leading designer, manufacturer and global provider of neonatal ventilation products. The Group generates approximately 58% of its revenues from export markets and more than half of its revenues come from its own-branded products.
With product availability actively promoted to over 80 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.
In the UK and Ireland, the Group has direct sales teams selling Group Branded and complementary products from third parties, with an additional range of home healthcare products. This is supported by Technical Support for planned preventative maintenance and emergency assistance.
The Group operates from various sites in the UK for R&D, Marketing and operations with manufacturing based in Croydon (south London) and Hailsham (East Sussex). The Group's Head Office is located in Crawley, a short distance from London's Gatwick Airport.
Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com